SEC Form 4 · accession 0001140361-16-082160
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter C Farrell
Director
Period of report
Oct 4, 2016
Accepted (ET)
Oct 6, 2016 · 3:59 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock | Oct 4, 2016 | M | 16,085 | $25.54 | A | 364,063 | D | |
| ResMed Common Stock | Oct 4, 2016 | M | 2,967 | $33.70 | A | 367,030 | D | |
| ResMed Common Stock | Oct 4, 2016 | M | 948 | $33.70 | A | 367,978 | D | |
| ResMed Common StockF2 | Oct 4, 2016 | S | 20,000 | $64.698 | D | 347,978 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Resmed Stock Option PlanF3 | $25.54 | Oct 4, 2016 | M | 16,085 | D | Dec 17, 2010 | Dec 17, 2016 | ResMed Common Stock | 16,085 | 0 | D |
| Resmed Stock Option PlanF3 | $33.70 | Oct 4, 2016 | M | 948 | D | Nov 11, 2011 | Nov 11, 2017 | ResMed Common Stock | 948 | 96,085 | D |
| Resmed Stock Option PlanF3 | $33.70 | Oct 4, 2016 | M | 2,967 | D | Nov 11, 2011 | Nov 11, 2017 | ResMed Common Stock | 2,967 | 0 | D |
Explanation of responses
- F1The transaction was conducted under a Rule 10b5-1 plan.
- F2This transaction was executed in multiple trades at prices ranging from 64.32 to 65.20. The price reported above represents the weighted average sales price.
- F3Represents date options first became exercisable. Options vested 1/4 per year.